The global scar treatment market size reached US$ 14.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028.
Scar treatment refers to the techniques and procedures employed for the remedy of acne, keloid, contracture, hypertrophic scars, etc. Scars are visible wound marks caused by surgeries, injuries or infections. The treatment and revision procedures are employed to minimize the appearance of these scars so that they look more consistent with the surrounding skin tone and texture. In order to speed up the healing process, various treatments are used, including over the counter (OTC) gels, ointments, creams, silicone sheets; surgeries for skin grafts, excisions or laser treatment; and collagen injections. In some cases, topical creams enriched with Vitamin E are also applied to diminish post-surgery scars.
The increasing prevalence of skin diseases, along with the rising consumer awareness regarding various scar treatment options, represent as the key factors driving the growth of the market. The growing aesthetic sense among the masses has led to the widespread adoption of skin treatment procedures. Furthermore, enhanced accessibility to dermatological facilities and the introduction of products containing both chemical and herbal ingredients are boosting the overall demand for the service. Dermatological clinics offer precise and latest technological procedures for cosmetic surgeries that provide effective results and cause minimal discomfort to the patient. Additionally, surgeries conducted using laser instruments are used for reducing the visibility of scars after critical injuries. These surgeries also speed up the healing process while ensuring a painless experience for the patient. Other factors, such as rising urbanization, inflating disposable incomes and the increase in affluent population, aggressive promotional activities by service providers and the introduction of organic and natural products, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global scar treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product or treatment type, scar type and end-user.
Breakup by Product or Treatment Type:
Breakup by Scar Type:
Hypertrophic and Keloid Scars
Breakup by End-User:
Breakup by Region:
Middle East and Africa
United Arab Emirates
The competitive landscape of the industry has also been examined with some of the key players being Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC and Sonoma Pharmaceuticals Inc., etc.
Base Year of the Analysis
Product or Treatment Type, Scar Type, End-User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Saudi Arabia, Iran, United Arab Emirates
Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC and Sonoma Pharmaceuticals Inc.
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global scar treatment market was valued at US$ 14.3 Billion in 2022.
We expect the global scar treatment market to exhibit a CAGR of 8.8% during 2023-2028.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cosmetic surgeries for scar treatment to reduce the risk of the coronavirus infection among the patients upon hospital visits and interaction with healthcare professionals or medical equipment.
The rising prevalence of various skin diseases, along with the increasing adoption of numerous laser instruments for reducing the visibility of scars after critical injuries, while ensuring a painless experience for the patient, is primarily driving the global scar treatment market.
Based on the product or treatment type, the global scar treatment market can be categorized topical products, laser treatment, surface treatment, and injectables. Currently, topical products hold the majority of the total market share.
Based on the scar type, the global scar treatment market has been segmented into atrophic scars, hypertrophic and keloid scars, contracture scars, and others. Among these, atrophic scars exhibit a clear dominance in the market.
Based on the end-user, the global scar treatment market can be bifurcated into hospitals, clinics, retail pharmacies, others. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into Asia Pacific, North America, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global scar treatment market include Alliance Pharma PLC, AVITA Medical Ltd., Bausch Health Companies Inc., Cutera, Inc., Establishment Labs SA, GC Aesthetics PLC, Hologic Inc., Mölnlycke Health Care AB, Smith & Nephew PLC, Sonoma Pharmaceuticals Inc., etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.